Portfolio Update

RNS Number : 3557A
Chrysalis Investments Limited
01 February 2022
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.

 

01 February 2022

 

 

Chrysalis Investments Limited (the "Company")

 

Portfolio Update

 

The Company is pleased to confirm that the sale of its shareholding in Embark Group Limited to Scottish Widows Group Limited, a subsidiary of Lloyds Banking Group plc has now completed. The Company has received net cash proceeds of £57.2m for the sale, which represents a cash-on-cash return of 2.1x from the date of the Company's initial investment in July 2019. 

 

 

Nick Williamson and Richard Watts, co-portfolio managers, commented:

 

"Following last year's IPO of Wise, this transaction represents a further realisation from the portfolio. We are delighted with the outcome of this transaction which we believe is a fantastic result for our shareholders. 

 

We would like to thank the management team at Embark for their hard work during this transaction and wish them and the team at Lloyds good luck with the integration of the Embark business." 

 

 

 

-ENDS-

 

For further information, please contact:

 

Jupiter Asset Management:

Magnus Spence

 

 

 

+44 (0) 20 3817 1325

Liberum Capital Limited:

Chris Clarke / Darren Vickers / Owen Matthews

 

+44 (0) 20 3100 2000

Numis Securities Limited:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

 

+44 (0) 1481 749364

 

 

Media Enquiries:

 

Montfort Communications

Charlotte McMullen

 

 

+44 (0) 20 3514 0897

Chrysalis@montfort.london

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at http://chrysalisinvestments.co.uk . Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

 

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFLFISFFILIIF
UK 100

Latest directors dealings